Positron Emission Tomography (PET) Markets

1. Overview

• 1.1 Statement of Report
• 1.2 Scope of this Report
• 1.3 Methodology
• 1.4 Executive Summary

2. Overview of the Medical Imaging Market

• 2.1 Medical Imaging Industry Market Size
• 2.2 Medical Imaging Infrastructure
  • 2.2.1 Total Healthcare Expenditures and Demographics
  • 2.2.2 Number of Hospitals
  • 2.2.3 Number of Radiologists
  • 2.2.4 Radiologic Services
  • 2.2.5 Medical Imaging Companies
  • 2.2.6 Medical Imaging Market Drivers
  • 2.2.7 Market Restraints
  • 2.2.8 Market Segments for PET Imaging
  • 2.2.9 Key Players in the PET Imaging Segment
  • 2.2.10 Medical Imaging Sector Analysis
• 2.3 Structure and Use of PET Imaging
  • 2.3.1 Functional Imaging versus Anatomic Imaging
  • 2.3.2 Functional Imaging Using Single-Photon Imaging (SPECT)
  • 2.3.3 PET in Clinical Use
  • 2.3.4 PET Sensitivity
  • 2.3.5 Therapeutic Uses of PET
  • 2.3.6 PET/CT
  • 2.3.7 The Future of PET in Cancer Imaging
  • 2.3.8 PET Reimbursement
• 2.4 Radiopharmaceutical Imaging
  • 2.4.1 Cardinal Health Acquires PET Radiopharmaceutical Production Facilities
  • 2.4.2 GE Healthcare Launches New Platform for Automated Synthesis of PET Radiopharmaceuticals
  • 2.4.3 Siemens Medical PETNET Radiopharmacy
  • 2.4.4 Future Growth of PET Imaging Procedures
  • 2.4.5 Diagnostic Radiopharmaceuticals: Market Analysis and Future Prospects
  • 2.4.6 New Radiopharmaceutical Applications

3. PET Market

• 3.1 Market Size
• 3.2 Total PET and PET/CT Market Trends
  • 3.2.1 Market Segmentation and Definitions
  • 3.2.2 Overview
  • 3.2.3 Market Measurements
  • 3.2.4 Market Drivers
  • 3.2.5 Market Restraints
  • 3.2.6 Future Needs for Market Development
  • 3.2.7 Clinical Usages
• 3.3 Total PET and PET/CT Market Forecasts
  • 3.3.1 Revenue Forecasts
  • 3.3.2 Unit Shipment Forecasts
  • 3.3.3 Procedure Forecast
  • 3.3.4 Competitive Structure
  • 3.3.5 Market Share Analysis
  • 3.3.6 Future Directions for PET
  • 3.3.7 New PET Technology Platforms
• 3.4 SPECT Market Forecasts
• 3.5 Stand-Alone PET Market Forecasts
  • 3.5.1 Revenue Forecasts
  • 3.5.2 Unit Shipment Forecasts
  • 3.5.3 Market Share Analysis
• 3.6 PET/CT Market Forecasts
  • 3.6.1 PET/CT Revenue Forecasts
  • 3.6.2 PET/CT Unit Shipment Forecasts
  • 3.6.3 PET/CT Market Share Analysis
• 3.7 Products
  • 3.7.1 Gamma Medica
  • 3.7.2 Mallinckrodt
  • 3.7.3 Naviscan PET Systems
  • 3.7.4 Siemens Medical
  • 3.7.5 TeraRecon
  • 3.7.6 Toshiba America Medical Systems
  • 3.7.7 CTI Molecular Imaging Inc.
  • 3.7.8 GE Healthcare
  • 3.7.9 Philips Medical Systems
  • 3.7.10 MedImage Inc.

4. PET/CT

• 4.1 Strengths of CT and PET Scanning
• 4.2 Combining CT' s Strengths with PET Scanning
• 4.3 Nuclear Medicine Safety Protocols
• 4.4 PET Safety Protocols
  • 4.4.1 Radiation Safety
  • 4.4.2 Appropriate Shielding
  • 4.4.3 Radioactive Package Protocols
• 4.5 Regulatory Requirements
• 4.6 PET and SPECT Tracers
  • 4.6.1 FDG Centers
• 4.7 PET Imaging
• 4.8 PET and Cancer Staging
• 4.9 PET/CT Reimbursement

5. Hybrid Technology: PET/CT and SPECT/CT

• 5.1 PET/CT
• 5.2 SPECT/CT
• 5.2.1 Blending of Technology Platforms
• 5.2.2 SPECT vs. PET

6. SPECT and SPECT/CT

• 6.1 Single-Photon Emission Computed Tomography (SPECT)
  • 6.1.1 SPECT Imaging
• 6.2 SPECT/CT
• 6.3 Potential Applications of SPECT/CT
• 6.4 New Technology Platforms: SPECT

7. Clinical PET/CT for Oncology Applications

• 7.1 Pulmonary Nodules
• 7.2 Non-Small-Cell Lung Cancer
• 7.3 Melanoma
• 7.4 Lymphoma
• 7.5 Colorectal Cancer
• 7.6 Head and Neck Cancer
• 7.7 Esophageal Cancer
• 7.8 Breast Cancer
• 7.9 Brain Cancer
• 7.10 Prostate Cancer
• 7.11 Ovarian Cancer
• 7.12 Cervical Cancer
• 7.13 Testicular Cancer
• 7.14 Thyroid Cancer
• 7.15 Pancreatic Cancer
• 7.16 Trends in Clinical Use of PET/CT
• 7.17 Development of PET/MRI

8. Company Listings

Appendix 1. Radiopharmaceutical Diagnostic Imaging Agent Codes and PET Scan Services

• Table 2.1: U.S. Medical Imaging Market Size, 2001 to 2010
• Table 2.2: Global Medical Imaging Market Size, 2001 to 2010
• Table 2.3: U.S. Healthcare Expenditures, 1999 to 2010
• Table 2.4: U.S. Health Expenditures as a Percentage of GDP, 1999 to 2010
• Table 2.5: U.S. User Expenditures for Medical Imaging Equipment and Related Products
• Table 3.1: Type of Imaging Offered by Facility
• Table 3.2: PET Procedures by Type
• Table 3.3: PET Patient Studies Performed in U.S.
• Table 3.4: Worldwide Dollar Sales of PET Imaging Systems, 2004 to 2011
• Table 3.5: U.S. Dollar Sales of PET Imaging Systems, 2004 to 2011
• Table 3.6: Average Selling Price for PET, U.S. and Worldwide, 2004 to 2011
• Table 3.7: Unit Sales of PET Imaging Systems, U.S. and Worldwide, 2004 to 2011
• Table 3.8: Installed Base of PET Imaging Systems, U.S., 2004 to 2011
• Table 3.9: PET Procedure Volume, 2004 to 2011
• Table 3.10: FDG Sales, 2004 to 2011
• Table 3.11: SPECT Procedure Volume, 2004 to 2011
• Table 3.12: U.S. SPECT Scanner Market Size and Growth, 2002 to 2010
• Table 3.13: U.S. Stand-Alone PET Scanner Market Size and Growth, 2004 to 2011
• Table 3.14: U.S. PET/CT Scanner Market Size and Growth, 2002 to 2010
• Table 4.1: PET Applications Approved for Reimbursement by CMS
• Table 5.1: SPECT and PET Hybrid Sales Percentages